Thyrotoxicosis in children and adolescents – diagnostic and therapeutic dilemmas

Thyrotoxicosis is caused by diff erent etiologic factors and is manifested by various clinical signs of hypermetabolism. Appropriate therapeutic approach demands prompt and correct diagnosis and depends on the cause and condition of the patient. This article presents a clinical review of thyrotoxicosis treatment based on clinically acquired data and brings a review of personal experiences during a 14-year period. We searched the literature, on PubMed and other published materials. We compared our experience at Clinical Department of Pediatrics, Split University Hospital Center, with experiences of others. Clinical description includes initial evaluation and approach to thyrotoxicosis; subclinical hyperthyroidism/thyrotoxicosis; Hashimoto’s and Graves’ disease, and approach to Graves’ hyperthyroidism including antithyroid drugs, radioactive iodine and surgical treatment. During the 14-year period, we examined 59 patients with thyrotoxicosis, including 7/59 (28.8%) patients diagnosed with Hashimoto’s disease, 41/59 (69.5%) patients diagnosed with Graves’ disease, and 1/59 (1.7%) patient diagnosed with rare thyroxine binding globulin (TBG) insuffi ciency. Twelve of 41 (29.2%) patients with Graves’ disease had remission and relapse occurred in one-third (n=4) of these 12 (33.3%) patients. Radioiodine therapy was used in 3/41 (7.3%) patients with Graves’ disease, whereas 13/41 (31.7%) patients underwent surgical operation. Many recommendations and conclusions have been drawn on the basis of clinical data on the rational, safe and optimal medical approach to patients with thyrotoxicosis. Choosing treatment for Graves’ disease is a complex process. Discussing advantages and risks of recommended therapies with patients and parents is desirable and necessary. In our institution, it is necessary to encourage parents of Graves’ disease patients with minor chance of remission to make quick decision on defi nitive care. Key words: thyrotoxicosis; Graves disease; Hashimoto disease; antithyroid agents; thyroidectomy; beta-iodoalanine
Keywords:
Category: Original scientific paper
Volume: Vol. 61, No 1, january - march 2017
Authors: Veselin Škrabić, Ivana Unić, Samira Bilalić, Roko Škrabić
Reference work: Paediatr Croat. 2017;61:1-9
DOI: http://dx.doi.org/10.13112/PC.2017.1

 The whole article is viewable only to subscribers! If you are a subscriber please login.